Adenovirus type 4 and type 7
Ended Awarded
- Contract number
- SPE2DP26F7471
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $343,526
Award facts
- Contract value 100% obligated
- $343,526.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Department's Medical Supply Chain issued a $343,526.40 delivery order to Teva Pharmaceuticals USA, Inc. on July 14, 2026, for Adenovirus Type 4 and Type 7 vaccine supply.
Place of performance is Parsippany, New Jersey. The order is firm fixed price with an ultimate completion date of July 21, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DP26F7471?
SPE2DP26F7471 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on July 14, 2026.
How much is contract SPE2DP26F7471 worth?
The government has obligated $343,526 on SPE2DP26F7471.
Is contract SPE2DP26F7471 an order under another contract?
Yes. SPE2DP26F7471 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F7471 competed?
The extent of competition for SPE2DP26F7471 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award